This Week in NEJM

Premium

In NEJM this week, researchers in the UK report on the efficacy of radiotherapy for the treatment of muscle-invasive bladder cancer. The team randomly assigned 360 bladder cancer patients to undergo radiotherapy with or without synchronous chemotherapy. The two-year locoregional disease-free survival rate for the combination radiotherapy/chemotherapy group was 67 percent compared to 54 percent for the radiotherapy alone group, the team found.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.

Adam Rutherford discusses genetic genealogy at the Guardian.

Portions of the US 21st Century Cures Act are raising some safety concerns.

David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.